期刊文献+

二氢嘧啶脱氢酶基因多态性研究的现状与进展

原文传递
导出
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第12期1313-1315,共3页 Chinese Journal of Laboratory Medicine
基金 卫生部北京医院重点科研资助项目(200208)
  • 相关文献

参考文献27

  • 1陈新谦 金有豫 汤光.新编药物学(第15版)[M].北京:人民卫生出版社,2004.226.
  • 2Heggie GD,Sommadossi JP,Cross DS,et al.Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma,urine,and bile.Cancer Res,1987,47:2203-2206.
  • 3Diasio RB,Beavers TL,Carpenter JT.Familial deficiency of dihydropyrimidine dehydrogenase biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.J Clin Invest,1988,81:47-51.
  • 4Harris BE,Carpenter JT,Diasio RB.Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency.Cancer,1991,68:499-501.
  • 5Lu Z,Zhang R,Diasio RB.Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver:population characteristics,newly identified deficient patients,and clinical implication in 5-fluorouracil chemotherapy.Cancer Res,1993,53:5433-5438.
  • 6Fleming RA,Milano G,Thyss A,et al.Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients.Cancer Res,1992,52:2899-2902.
  • 7Yokota H,Fernandez-Salguero P,Furuya H,et al.cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase,an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria.J Biol Chem,1994,269:23192-23196.
  • 8Johnson MR,Wang K,Tillmanns S,et al.Structural organization of the human dihydropyrimidine dehydrogenase gene.Cancer Res,1997,57:1660-1663.
  • 9Wei X,McLeod HL,McMurrough J,et al.Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.J Clin Invest,1996,98:610-615.
  • 10Wei X,Elizondo G,Sapone A,et al.Characterization of the human dihydropyrimidine dehydrogenase gene.Genomics,1998,51:391-400.

二级参考文献14

  • 1Tuchman M,Stoeckeler JS,Kiang DT, et al. Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity[J].N Engl J Med, 1985,313:245-249.
  • 2Diasio RB,Beavers TL,Carpenter JT. Familial deficiency of dihydropyrimidine dehydrogenase biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity[J].J Clin Invest, 1988,81:47-51.
  • 3Harris BE, Carpenter JT, Diasio RB. Severe 5- fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency[J]. Cancer, 1991,68:499-501.
  • 4Wei X, McLeod HL, McMurrough J,et al. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity[J].J Clin Invest, 1996,98:610-615.
  • 5Kouwaki M, Hamajima N, Sumi S,et al. Identification of novel mutations in the dihydropyrimidine dehydrogenase gene in a Japanese patient with 5-fluorouracil toxicity[J].Clin Cancer Res, 1998,4:2999-3004.
  • 6Vreken P, Van Kuilenburg ABP, Meinsma R,et al. Identification of novel point mutations in the dihydropyrimidine dehydrogenase gene[J]. J Inher Metab Dis, 1997,20:335-338.
  • 7Vreken P,Van Kuilenburg ABP,Meinsma R,et al. Identification of a four-base deletion (del TCAT296-299) in the dihydropyrimidine dehydrogenase gene with variable clinical expression[J].Hum Genet, 1997,100: 263-265.
  • 8Wei X, Elizondo G, Sapone A,et al. Characterization of the human dihydropyrimidine dehydrogenase gene[J]. Genomics,1998,51: 391-400.
  • 9Ridge SA,Sludden J,Wei X,et al. Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer[J]. Br J Cancer, 1998,77:497-500.
  • 10Ridge S A, Sludden J, Brown O,et al. Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects[J].Br J Clin Pharmacol,1998,46:151-156.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部